ImmunityBio, Inc. Annual Amortization of Intangible Assets in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
ImmunityBio, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2014 to 2023.
  • ImmunityBio, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
  • ImmunityBio, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $2M, a 5.26% increase year-over-year.
  • ImmunityBio, Inc. annual Amortization of Intangible Assets for 2023 was $2M, a 5.26% increase from 2022.
  • ImmunityBio, Inc. annual Amortization of Intangible Assets for 2022 was $1.9M.
  • ImmunityBio, Inc. annual Amortization of Intangible Assets for 2019 was $600K, a 73.9% decline from 2018.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2M +$100K +5.26% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.9M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2019 $600K -$1.7M -73.9% Jan 1, 2019 Dec 31, 2019 8-K/A 2021-04-22
2018 $2.3M $0 0% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-04
2017 $2.3M -$300K -11.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-25
2016 $2.6M +$1.3M +100% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $1.3M +$1.3M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.